342 related articles for article (PubMed ID: 25133536)
21. Oxytocin plasma concentrations after single intranasal oxytocin administration - a study in healthy men.
Gossen A; Hahn A; Westphal L; Prinz S; Schultz RT; Gründer G; Spreckelmeyer KN
Neuropeptides; 2012 Oct; 46(5):211-5. PubMed ID: 22884888
[TBL] [Abstract][Full Text] [Related]
22. A Spatiotemporal Profile of In Vivo Cerebral Blood Flow Changes Following Intranasal Oxytocin in Humans.
Paloyelis Y; Doyle OM; Zelaya FO; Maltezos S; Williams SC; Fotopoulou A; Howard MA
Biol Psychiatry; 2016 Apr; 79(8):693-705. PubMed ID: 25499958
[TBL] [Abstract][Full Text] [Related]
23. Peripherally administered non-peptide oxytocin antagonist, L368,899, accumulates in limbic brain areas: a new pharmacological tool for the study of social motivation in non-human primates.
Boccia ML; Goursaud AP; Bachevalier J; Anderson KD; Pedersen CA
Horm Behav; 2007 Sep; 52(3):344-51. PubMed ID: 17583705
[TBL] [Abstract][Full Text] [Related]
24. The relationship between central and peripheral oxytocin concentrations: a systematic review and meta-analysis protocol.
Valstad M; Alvares GA; Andreassen OA; Westlye LT; Quintana DS
Syst Rev; 2016 Mar; 5():49. PubMed ID: 27037015
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticle encapsulation increases the brain penetrance and duration of action of intranasal oxytocin.
Oppong-Damoah A; Zaman RU; D'Souza MJ; Murnane KS
Horm Behav; 2019 Feb; 108():20-29. PubMed ID: 30593782
[TBL] [Abstract][Full Text] [Related]
26. Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men.
Quintana DS; Westlye LT; Smerud KT; Mahmoud RA; Andreassen OA; Djupesland PG
Horm Behav; 2018 Jun; 102():85-92. PubMed ID: 29750971
[TBL] [Abstract][Full Text] [Related]
27. Salivary Oxytocin Concentrations in Males following Intranasal Administration of Oxytocin: A Double-Blind, Cross-Over Study.
Daughters K; Manstead AS; Hubble K; Rees A; Thapar A; van Goozen SH
PLoS One; 2015; 10(12):e0145104. PubMed ID: 26669935
[TBL] [Abstract][Full Text] [Related]
28. A comparison of methods to measure central and peripheral oxytocin concentrations in human and non-human primates.
Lefevre A; Mottolese R; Dirheimer M; Mottolese C; Duhamel JR; Sirigu A
Sci Rep; 2017 Dec; 7(1):17222. PubMed ID: 29222505
[TBL] [Abstract][Full Text] [Related]
29. Statistical and Methodological Considerations for the Interpretation of Intranasal Oxytocin Studies.
Walum H; Waldman ID; Young LJ
Biol Psychiatry; 2016 Feb; 79(3):251-7. PubMed ID: 26210057
[TBL] [Abstract][Full Text] [Related]
30. Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles.
Bales KL; Perkeybile AM; Conley OG; Lee MH; Guoynes CD; Downing GM; Yun CR; Solomon M; Jacob S; Mendoza SP
Biol Psychiatry; 2013 Aug; 74(3):180-8. PubMed ID: 23079235
[TBL] [Abstract][Full Text] [Related]
31. Intranasal oxytocin as a treatment for anxiety and autism: From subclinical to clinical applications.
Yin H; Jiang M; Han T; Xu X
Peptides; 2024 Jun; 176():171211. PubMed ID: 38579916
[TBL] [Abstract][Full Text] [Related]
32. The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder.
Greene RK; Spanos M; Alderman C; Walsh E; Bizzell J; Mosner MG; Kinard JL; Stuber GD; Chandrasekhar T; Politte LC; Sikich L; Dichter GS
J Neurodev Disord; 2018 Mar; 10(1):12. PubMed ID: 29587625
[TBL] [Abstract][Full Text] [Related]
33. Potential shortcomings in current studies on the effect of intranasal oxytocin in Anorexia Nervosa and healthy controls - A systematic review and meta-analysis.
Hasselbalch KC; Lanng KR; Birkeland M; Sjögren M
Psychopharmacology (Berl); 2020 Oct; 237(10):2891-2903. PubMed ID: 32809046
[TBL] [Abstract][Full Text] [Related]
34. LC-MS/MS measurement of endogenous oxytocin in the posterior pituitary and CSF of macaques: A pilot study.
Erikson DW; Blue SW; Kaucher AV; Shnitko TA
Peptides; 2021 Jun; 140():170544. PubMed ID: 33811949
[TBL] [Abstract][Full Text] [Related]
35. No side-effects of single intranasal oxytocin administration in middle childhood.
Verhees MWFT; Houben J; Ceulemans E; Bakermans-Kranenburg MJ; van IJzendoorn MH; Bosmans G
Psychopharmacology (Berl); 2018 Aug; 235(8):2471-2477. PubMed ID: 29915962
[TBL] [Abstract][Full Text] [Related]
36. Intranasal oxytocin administration attenuates the ACTH stress response in monkeys.
Parker KJ; Buckmaster CL; Schatzberg AF; Lyons DM
Psychoneuroendocrinology; 2005 Oct; 30(9):924-9. PubMed ID: 15946803
[TBL] [Abstract][Full Text] [Related]
37. Cerebral and extracerebral distribution of radioactivity associated with oxytocin in rabbits after intranasal administration: Comparison of TTA-121, a newly developed oxytocin formulation, with Syntocinon.
Ishii D; Kageyama M; Umeda S
PLoS One; 2021; 16(12):e0261451. PubMed ID: 34929003
[TBL] [Abstract][Full Text] [Related]
38. Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.
Lee MR; Wehring HJ; McMahon RP; Liu F; Linthicum J; Verbalis JG; Buchanan RW; Strauss GP; Rubin LH; Kelly DL
Schizophr Res; 2016 Apr; 172(1-3):165-8. PubMed ID: 26879587
[TBL] [Abstract][Full Text] [Related]
39. Effects of Intranasal Oxytocin on Stress-Induced Cigarette Craving in Daily Smokers.
Van Hedger K; Bershad AK; Lee R; de Wit H
Nicotine Tob Res; 2020 Jan; 22(1):89-95. PubMed ID: 30085292
[TBL] [Abstract][Full Text] [Related]
40. The impact of oxytocin administration on brain activity: a systematic review and meta-analysis protocol.
Quintana DS; Outhred T; Westlye LT; Malhi GS; Andreassen OA
Syst Rev; 2016 Nov; 5(1):205. PubMed ID: 27899138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
